[Federal Register Volume 64, Number 23 (Thursday, February 4, 1999)]
[Notices]
[Pages 5664-5665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2688]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 99N-0123]
Agency Information Collection Activities: Proposed Collection;
Comment Request; Food Labeling; Notification Procedures for Statements
on Dietary Supplements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the regulation requiring
manufacturers, packers, and distributors of dietary supplements to
notify FDA that they are marketing a dietary supplement product that
bears on its label or in its labeling a statement provided for in the
Federal Food, Drug, and Cosmetic Act (the act).
DATES: Submit written comments on the collection of information by
April 5, 1999.
ADDRESSES: Submit written comments on the collection of information to
the Dockets Management Branch (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should
be identified with the docket number found in brackets in the heading
of this document.
FOR FURTHER INFORMATION CONTACT: Peggy Schlosburg, Office of
Information Resources Management (HFA-250), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth below.
With respect to the following collection of information, FDA
invites comments on: (1) Whether the proposed collection of information
is necessary for the proper performance of FDA's functions, including
whether the information will have practical utility; (2) the accuracy
of FDA's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.
Food Labeling; Notification Procedures for Statements on Dietary
Supplements--21 CFR 101.93 (OMB Control Number 0910-0331--
Extension)
Description: Section 403(r)(6) of the act (21 U.S.C. 343(r)(6))
requires that the agency be notified by manufacturers, packers, and
distributors of dietary supplements that they are marketing a dietary
supplement product that bears on its label or in its labeling a
statement provided for in section 403(r)(6) of the act. Section
403(r)(6) of the act requires that the agency be notified, with a
submission about such statements, no later than 30 days after the first
marketing of the dietary supplement. Information that is required in
the submission includes: (1) The name and address of the manufacturer,
packer, or distributor of the dietary supplement product; (2) the text
of the statement that is being made; (3) the name of the dietary
ingredient or supplement that is the subject of the statement; (4) the
name of the dietary supplement (including the brand name); and (5) a
signature of a responsible individual who can certify the accuracy of
the information presented.
The agency established Sec. 101.93 (21 CFR 101.93) as the
procedural regulation for this program. Section 101.93 provides details
of the procedures associated with the submission and identifies the
information that must be included in order to meet the requirements of
section 403 of the act.
Description of Respondents: Businesses or other for-profit
organizations.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden1
----------------------------------------------------------------------------------------------------------------
Annual
21 CFR Section No. of Frequency per Total Annual Hours per Total Hours
Respondents Response Responses Response
----------------------------------------------------------------------------------------------------------------
101.93 700 1 700 0.5 to 1 350 to 700
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
The agency believes that there will be minimal burden on the
industry to generate information to meet the requirements of section
403 of the act in submitting information regarding section 403(r)(6) of
the act statements on
[[Page 5665]]
labels or labeling of dietary supplements. The agency is requesting
only information that is immediately available to the manufacturer,
packer, or distributor of the dietary supplement that bears such a
statement on its label or in its labeling. This estimate is based on
the average number of notification submissions received by the agency
in the last 3 years.
Dated: January 29, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-2688 Filed 2-3-99; 8:45 am]
BILLING CODE 4160-01-F